Tissue of Origin: Breast
Cancer Type: Breast Carcinoma
SK-BR-07 is a human breast cancer cell line.
This cell line was established from a breast metastasis in a female with breast carcinoma.
- Jorgen Fogh, PhD, formerly of Sloan Kettering Institute, MSK
- Germaine Trempe, formerly of Sloan Kettering Institute, MSK
PubMed=11044355; DOI=10.1054/bjoc.2000.1458 Davidson J.M., Gorringe K.L., Chin S.-F., Orsetti B., Besret C., Courtay-Cahen C., Roberts I., Theillet C., Caldas C., Edwards P.A.W.Molecular cytogenetic analysis of breast cancer cell lines.Br. J. Cancer 83:1309-1317(2000)
This cell line may be licensed nonexclusively for research or commercial purposes.
For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.
To proceed, please download this contract, fill in all relevant fields, and email a scanned version to [email protected]. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.
For licensing requests for a commercial purpose: Contact MSK’s Tangible Materials team at [email protected].
For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354, [email protected].